Profile data is unavailable for this security.
About the company
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
- Revenue in GBP (TTM)272.00k
- Net income in GBP-5.00m
- Incorporated2007
- Employees43.00
- LocationGenedrive PLC48 Grafton StreetMANCHESTER M13 9XXUnited KingdomGBR
- Phone+44 161 989 0245
- Fax+44 161 989 0262
- Websitehttp://www.genedriveplc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Myhealthchecked PLC | 10.98m | -159.00k | 5.72m | 10.00 | -- | 0.8066 | 89.42 | 0.5214 | -0.0031 | -0.0031 | 0.2111 | 0.1674 | 0.8863 | 10.98 | 4.44 | 1,097,700.00 | -1.28 | -7.24 | -1.81 | -10.39 | 18.66 | 22.82 | -1.45 | -5.13 | 2.46 | -- | 0.003 | -- | -50.81 | 368.95 | -110.48 | -- | -2.00 | -- |
Surgical Innovations Group Plc | 12.01m | -509.00k | 5.93m | 101.00 | -- | 0.5783 | 23.91 | 0.4937 | -0.0005 | -0.0005 | 0.0129 | 0.0112 | 0.8032 | 2.85 | 5.89 | 118,950.50 | -3.40 | -8.19 | -4.18 | -9.94 | 28.70 | 32.51 | -4.24 | -13.31 | 1.23 | -4.45 | 0.1368 | -- | 5.94 | 1.84 | -292.80 | -- | 7.20 | -- |
Feedback plc | 886.00k | -3.49m | 6.20m | 24.00 | -- | 0.6096 | -- | 6.99 | -0.2614 | -0.2614 | 0.0664 | 0.6726 | 0.0774 | -- | 3.74 | 36,916.67 | -30.44 | -28.58 | -32.67 | -31.74 | 90.60 | 92.61 | -393.47 | -299.13 | -- | -- | 0.00 | -- | 74.15 | 17.46 | -37.74 | -- | 56.22 | -- |
Rua Life Sciences PLC | 2.19m | -1.44m | 6.98m | 33.00 | -- | 1.04 | -- | 3.19 | -0.0551 | -0.0551 | 0.0653 | 0.1157 | 0.3168 | 4.30 | 3.91 | 66,393.94 | -20.82 | -24.63 | -22.39 | -26.81 | 81.06 | -- | -65.72 | -97.07 | 8.81 | -23.34 | 0.0514 | -- | 0.5507 | 36.46 | 28.11 | -- | 122.88 | -- |
Cambridge Nutritional Sciences PLC | 9.77m | -328.00k | 8.03m | 94.00 | -- | 0.9093 | 24.94 | 0.8216 | -0.0015 | -0.0015 | 0.0411 | 0.0407 | 0.6908 | 5.39 | 4.62 | 103,978.70 | -2.32 | -11.43 | -2.60 | -12.98 | 61.86 | 58.79 | -3.36 | -26.72 | 5.03 | -- | 0.0151 | -- | 29.53 | 2.22 | 89.66 | -- | -53.43 | -- |
Proteome Sciences plc | 4.04m | -4.08m | 8.69m | 35.00 | -- | -- | -- | 2.15 | -0.0138 | -0.0138 | 0.0137 | -0.0178 | 0.3927 | 4.69 | 4.61 | 115,285.70 | -39.69 | -1.22 | -- | -- | 2.11 | 54.53 | -101.07 | -2.20 | 0.1388 | -3.70 | 1.63 | -- | -35.37 | 10.52 | -284.38 | -- | 126.22 | -- |
Genedrive PLC | 272.00k | -5.00m | 11.02m | 43.00 | -- | 1.93 | -- | 40.53 | -0.0407 | -0.0407 | 0.0022 | 0.0098 | 0.0658 | -- | 1.60 | 6,325.58 | -120.84 | -97.55 | -197.86 | -128.51 | -- | -- | -1,837.50 | -797.03 | 1.36 | -7.49 | 0.0789 | -- | 12.24 | -50.95 | -10.16 | -- | 16.72 | -- |
Genincode PLC | 2.16m | -7.02m | 11.68m | 36.00 | -- | 4.09 | -- | 5.41 | -0.0732 | -0.0732 | 0.0225 | 0.0135 | 0.2703 | 21.88 | 3.33 | 60,000.00 | -87.79 | -- | -124.10 | -- | 47.31 | -- | -324.81 | -- | 1.24 | -- | 0.1883 | -- | 51.05 | -- | -26.21 | -- | -- | -- |
Renalytix PLC | 2.54m | -34.56m | 15.47m | 80.00 | -- | 0.6306 | -- | 6.08 | -0.4231 | -0.4231 | 0.031 | 0.1472 | 0.0646 | 2.88 | 4.06 | 31,808.69 | -87.73 | -58.25 | -120.00 | -67.03 | 20.60 | -- | -1,358.30 | -1,904.79 | 1.71 | -9.62 | 0.397 | -- | 14.58 | -- | 18.52 | -- | -- | -- |
Ondine Biomedical Inc | 665.76k | -7.98m | 15.93m | 43.00 | -- | 13.50 | -- | 23.92 | -0.0405 | -0.0405 | 0.0034 | 0.0051 | 0.1079 | 0.4237 | 4.74 | -- | -129.24 | -- | -193.37 | -- | 58.44 | -- | -1,198.01 | -- | 1.06 | -- | 0.206 | -- | 88.56 | -- | 25.60 | -- | -- | -- |
Verici DX PLC | 3.24m | -3.60m | 16.06m | 19.00 | -- | 2.23 | -- | 4.96 | -0.0197 | -0.0197 | 0.0165 | 0.0304 | 0.4038 | -- | 5.71 | 231,437.90 | -44.82 | -- | -58.12 | -- | 77.06 | -- | -110.99 | -- | -- | -- | 0.0183 | -- | -- | -- | 23.43 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Peel Hunt LLPas of 24 Jun 2024 | 54.27m | 9.99% |
Hargreaves Lansdown Asset Management Ltd.as of 01 Jan 2022 | 5.48m | 1.01% |
Jarvis Investment Management Ltd.as of 14 Jun 2023 | 2.95m | 0.54% |
IG Markets Ltd.as of 01 Jan 2022 | 2.74m | 0.50% |
Rathbones Investment Management Ltd.as of 01 Jan 2022 | 2.35m | 0.43% |
HSBC Global Asset Management (UK) Ltd.as of 01 Jan 2022 | 2.21m | 0.41% |
BGF Investment Management Ltd.as of 05 Feb 2021 | 1.91m | 0.35% |
Walker Crips Investment Management Ltd.as of 01 Jan 2022 | 1.90m | 0.35% |
M&G Investment Management Ltd.as of 05 Feb 2020 | 1.76m | 0.32% |
Unicorn Asset Management Ltd.as of 31 Jul 2024 | 1.15m | 0.21% |